Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis E Virus
Reports outline hepatitis E virus study results from F.B. Riquet et al
November 5th, 2008
According to recent research from Paris, France, "Pathogenic circulating vaccine-derived polioviruses (cVDPVs) have become a major obstacle to the successful completion of the global polio eradication program." "Most cVDPVs are recombinant between the oral poliovirus vaccine (OPV) and human enterovirus species C (HEV-C). To study the role of HEV-C sequences in the phenotype of cVDPVs, we generated a series of recombinants between a Madagascar cVDPV isolate and its parental OPV type 2 strain," wrote F.B. Riquet and colleagues. The researchers concluded: "Results indicated that the HEV-C sequences present in this cVDPV contribute to its...
Source: Vaccine Weekly (2008-11-05)
|
